Most humoral non-responders to hepatitis B vaccines develop HBV-specific cellular immune responses.

[1]  M. Salazar,et al.  Normal HBsAg presentation and T-cell defect in the immune response of nonresponders , 2004, Immunogenetics.

[2]  M. Roncarolo,et al.  Type 1 T regulatory cells , 2001, Immunological reviews.

[3]  C. Tinelli,et al.  Increment of recombinant hepatitis B surface antigen-specific T-cell precursors after revaccination of slow responder children. , 2001, Vaccine.

[4]  C. Larsen,et al.  Complex cytokine responses to hepatitis B surface antigen and tetanus toxoid in responders, nonresponders and subjects naive to hepatitis B surface antigen. , 2000, Vaccine.

[5]  B. Marrone,et al.  Detection of beryllium sensitivity using a flow cytometric lymphocyte proliferation test: the Immuno-Be-LPT. , 2000, Toxicology.

[6]  A. Sette,et al.  Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans. , 1999, Journal of immunology.

[7]  A. Frydén,et al.  Intradermal hepatitis B vaccination in health care workers. Response rate and experiences from vaccination in clinical practise. , 1999, Scandinavian journal of infectious diseases.

[8]  H. Margolis,et al.  Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection. , 1998, American journal of preventive medicine.

[9]  E. Muchmore,et al.  Evaluation of B and T-cell responses in chimpanzees immunized with Hepagene, a hepatitis B vaccine containing pre-S1, pre-S2 gene products. , 1998, Vaccine.

[10]  D. Milich.  Pathobiology of acute and chronic hepatitis B virus infection: an introduction , 1997, Journal of viral hepatitis.

[11]  E. Yunis,et al.  Defect in Th1-like cells of nonresponders to hepatitis B vaccine. , 1997, Human immunology.

[12]  I. Hutchinson,et al.  Cytokine gene polymorphism and heart transplant rejection. , 1997, Transplantation.

[13]  M. Béné,et al.  Sequential Assessment of Cell Cycle S Phase in Flow Cytometry: A Non-Isotopic Method to Measure Lymphocyte Activation In Vitro , 1997, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[14]  T. Mosmann,et al.  The expanding universe of T-cell subsets: Th1, Th2 and more. , 1996, Immunology today.

[15]  G. Leroux-Roels,et al.  Nonresponders to hepatitis B vaccine can present envelope particles to T lymphocytes. , 1995, Journal of immunology.

[16]  G. Vanham,et al.  Deficient T-cell responses in non-responders to hepatitis B vaccination: absence of TH1 cytokine production. , 1994, Immunology letters.

[17]  G. Leroux-Roels,et al.  Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines. , 1994, Vaccine.

[18]  E. Yunis,et al.  The immune response to hepatitis B vaccine in humans: inheritance patterns in families , 1992, The Journal of experimental medicine.

[19]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[20]  C. Crumpacker,et al.  Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings. , 1986, Annals of internal medicine.

[21]  M. Tong,et al.  Alterations in the immune response of nonresponders to the hepatitis B vaccine. , 1985, The Journal of infectious diseases.

[22]  C. Crumpacker,et al.  Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy. , 1984, Annals of internal medicine.

[23]  J. Jett,et al.  MATHEMATICAL ANALYSIS OF DNA DISTRIBUTIONS DERIVED FROM FLOW MICROFLUOROMETRY , 1974, The Journal of cell biology.